|
US4036840A
(en)
*
|
1972-06-07 |
1977-07-19 |
Icn Pharmaceuticals |
2-Substituted-s-triazolo[1,5a]pyrimidines
|
|
AU676993B2
(en)
|
1991-06-27 |
1997-04-10 |
Virginia Commonwealth University |
Sigma receptor ligands and the use thereof
|
|
TR200002182T2
(tr)
|
1998-01-27 |
2000-12-21 |
Aventis Pharmaceuticals Products Inc. |
İkame edilmiş aksozaherosayklil faktör xa inhibitörleri
|
|
US6194410B1
(en)
|
1998-03-11 |
2001-02-27 |
Hoffman-La Roche Inc. |
Pyrazolopyrimidine and pyrazolines and process for preparation thereof
|
|
US20040014744A1
(en)
|
2002-04-05 |
2004-01-22 |
Fortuna Haviv |
Substituted pyridines having antiangiogenic activity
|
|
US20040180880A1
(en)
|
2002-10-03 |
2004-09-16 |
Lauffer David J. |
Piperazine and piperidine derivatives
|
|
EP1644003A1
(en)
|
2003-06-04 |
2006-04-12 |
Vernalis (Cambridge) Limited |
Triazolo ´1,5-a!pyrimidines and their use in medicine
|
|
EP1781659B1
(en)
|
2003-07-16 |
2008-11-05 |
Janssen Pharmaceutica N.V. |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
|
|
BRPI0418212A
(pt)
|
2003-12-29 |
2007-04-27 |
Banyu Pharma Co Ltd |
composto ou um sal deste farmaceuticamente aceitável, ativador da glicocinase, e, medicamentos para a terapia e/ou prevenção da diabete, e da obesidade
|
|
BRPI0515500A
(pt)
|
2004-09-20 |
2008-07-29 |
Xenon Pharmaceuticals Inc |
derivados piridazina para inibição de estearoil-coa-desaturase
|
|
AU2005286647A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
|
EP1812439B2
(en)
|
2004-10-15 |
2017-12-06 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
WO2006075023A2
(en)
*
|
2005-01-14 |
2006-07-20 |
Janssen Pharmaceutica N.V. |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
|
|
US7507842B2
(en)
|
2005-08-12 |
2009-03-24 |
Radiorx, Inc. |
Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
|
|
WO2007113136A1
(de)
|
2006-03-30 |
2007-10-11 |
Basf Aktiengesellschaft |
Verwendung von substituierten riazolopyrimidinen zur bekämpfung von phyto pathogenen schadpilzen
|
|
JP2007332061A
(ja)
|
2006-06-14 |
2007-12-27 |
Nippon Kayaku Co Ltd |
新規ピラゾロ［１，５−ａ］ピリミジン誘導体及びその用途
|
|
US8153803B2
(en)
|
2006-07-18 |
2012-04-10 |
The General Hospital Corporation |
Compositions and methods for modulating sirtuin activity
|
|
WO2008048914A1
(en)
|
2006-10-17 |
2008-04-24 |
Boehringer Ingelheim International Gmbh |
Polycyclic compounds which modulate the cb2 receptor
|
|
EA201070158A1
(ru)
*
|
2007-07-18 |
2010-08-30 |
Янссен Фармацевтика Н.В. |
Сульфонамиды в качестве trpm8 модуляторов
|
|
US8138168B1
(en)
|
2007-09-26 |
2012-03-20 |
Takeda Pharmaceutical Company Limited |
Renin inhibitors
|
|
GB0719803D0
(en)
|
2007-10-10 |
2007-11-21 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
CN101560212B
(zh)
*
|
2009-05-26 |
2011-03-16 |
华中师范大学 |
1,2,4-三唑并[1,5-a]嘧啶-2-乙基硫醚双取代衍生物的制备及其应用
|
|
WO2012080729A2
(en)
|
2010-12-14 |
2012-06-21 |
Electrophoretics Limited |
CASEIN KINASE 1δ (CK1δ) INHIBITORS
|
|
KR101548443B1
(ko)
|
2011-02-23 |
2015-08-28 |
화이자 인코포레이티드 |
신경 장애의 치료를 위한 이미다조[5,1-f][1,2,4]트라이아진
|
|
WO2013000924A1
(en)
|
2011-06-27 |
2013-01-03 |
Janssen Pharmaceutica Nv |
1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES
|
|
WO2013042139A1
(en)
|
2011-09-23 |
2013-03-28 |
Advinus Therapeutics Limited |
Amide compounds, compositions and applications thereof
|
|
CN103183675A
(zh)
*
|
2011-12-27 |
2013-07-03 |
山东轩竹医药科技有限公司 |
磷酸二酯酶-4抑制剂
|
|
US9034882B2
(en)
|
2012-03-05 |
2015-05-19 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
CN104302649B
(zh)
|
2012-03-09 |
2017-06-23 |
莱西肯医药有限公司 |
基于吡唑并[1,5‑a]嘧啶的化合物、包含它们的组合物及其使用方法
|
|
US9193736B2
(en)
*
|
2013-06-11 |
2015-11-24 |
Janssen Pharmaceutica, Nv |
PDE 10a inhibitors for the treatment of type II diabetes
|
|
US9328095B2
(en)
*
|
2013-10-15 |
2016-05-03 |
Janssen Pharmaceutica Nv |
Heteroaryl linked quinolinyl modulators of RORgammat
|
|
CA2936886A1
(en)
|
2014-02-27 |
2015-08-03 |
Merck Patent Gmbh |
Heterocyclic compounds as nav channel inhibitors and uses thereof
|
|
AU2015233654B2
(en)
|
2014-03-19 |
2018-12-06 |
Boehringer Ingelheim International Gmbh |
Heteroaryl Syk inhibitors
|
|
HUE057317T2
(hu)
|
2014-04-23 |
2022-04-28 |
Dart Neuroscience Llc |
Helyettesített [1,2,4]triazolo[1,5-A]pirimidin-7-IL vegyületeket tartalmazó készítmények mint PDE2 inhibítorok
|
|
CN105566321B
(zh)
|
2014-10-29 |
2020-04-21 |
广东东阳光药业有限公司 |
杂芳化合物及其在药物中的应用
|
|
CN105753817A
(zh)
|
2015-01-01 |
2016-07-13 |
成都贝斯凯瑞生物科技有限公司 |
一类取代氮杂环衍生物及其应用
|
|
WO2016145614A1
(en)
|
2015-03-17 |
2016-09-22 |
Merck Sharp & Dohme Corp. |
Triazolyl pyrimidinone compounds as pde2 inhibitors
|
|
WO2017000276A1
(en)
|
2015-07-01 |
2017-01-05 |
Merck Sharp & Dohme Corp. |
Bicyclic heterocyclic compounds as pde2 inhibitors
|
|
WO2017000277A1
(en)
|
2015-07-01 |
2017-01-05 |
Merck Sharp & Dohme Corp. |
Substituted triazolo bicycliccompounds as pde2 inhibitors
|
|
WO2017066705A1
(en)
|
2015-10-14 |
2017-04-20 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
|
ES2765738T3
(es)
|
2015-11-02 |
2020-06-10 |
Janssen Pharmaceutica Nv |
Compuesto de [1,2,4]triazolo[1,5-a]pirimidin-7-ilo
|
|
WO2017157882A1
(en)
|
2016-03-14 |
2017-09-21 |
Université Catholique de Louvain |
Serine biosynthetic pathway inhibitors
|
|
MX385576B
(es)
*
|
2016-11-02 |
2025-03-18 |
Janssen Pharmaceutica Nv |
Derivados de [1,2,4]triazol[1,5-a]pirimidina como inhibidores de pde2
|
|
CA3038916A1
(en)
|
2016-11-02 |
2018-05-11 |
Janssen Pharmaceutica Nv |
[1,2,4]triazolo[1,5-a]pyrimidine compounds as pde2 inhibitors
|
|
AU2017353313C1
(en)
|
2016-11-02 |
2022-06-09 |
Janssen Pharmaceutica Nv |
(1,2,4)triazolo(1,5-a)pyrimidine compounds as PDE2 inhibitors
|
|
US20190359609A1
(en)
|
2016-12-16 |
2019-11-28 |
Janssen Pharmaceutica Nv |
Bicyclic oga inhibitor compounds
|